Tardive Oromandibular Dystonia Induced by Trazodone: A Clinical Case and Management from the Perspective of the Dental Specialist

Simple item page
dc.coverageDOI: 10.3390/toxins14100680
dc.creatorSkármeta, Nicolas Patricio
dc.creatorKatzmann, Giannina C.
dc.creatorValdes Kufferath, Constanza
dc.creatorGaedechens, Dominique
dc.creatorMontini, Francisca Carolina
dc.date2022
dc.date.accessioned2025-11-18T19:55:33Z
dc.date.available2025-11-18T19:55:33Z
dc.descriptionBackground: Tardive Oromandibular Dystonia is an iatrogenic drug-induced movement form of extrapyramidal symptoms associated primarily with chronic consumption of dopamine receptor blocking agents. Tardive symptoms attributable to selective serotonin reuptake inhibitors antidepressants are far less prevalent. Clinical Case: The authors will present a clinical case and management, from the dental specialist perspective, of a 55-year-old female patient who developed tardive oromandibular dystonia induced by Trazodone prescribed for sleep insomnia. Conclusions: Trazodone-induced oromandibular dystonia is extremely rare. Early identification and assessment of tardive symptoms are imperative for successful treatment. Trazodone should be prescribed with caution in patients taking other medications with the potential to cause tardive syndromes.eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/89864f05-b055-48d5-8883-d9a1ddf974ce
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/59320
dc.languageeng
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.14 (2022) date: 2022-09-30 nr.10 p.1-7
dc.subjectbotulinum toxin
dc.subjectoromandibular dystonia
dc.subjecttardive dystonia
dc.subjecttrazodone
dc.titleTardive Oromandibular Dystonia Induced by Trazodone: A Clinical Case and Management from the Perspective of the Dental Specialisteng
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
PURE